Today on Drug Discovery & Development
Pitt’s high-performance computing upgrade signals accelerated translational research
The University of Pittsburgh’s recent, significant expansion of its high-performance computing capabilities, courtesy of a gift from Dell Technologies, indicates a strategic commitment to using large-scale data analysis for faster translational research. The additional 9.672 gigaFLOPS of computational power – translating to nearly 9.7 trillion additional computations per second – could help Pitt’s Innovation Hub…GLP-1s overtake metformin in metabolic clinical trials by a wide margin: A visual exploration
A recent review of more than 2,000 studies related at least indirectly to obesity on clinicaltrials.gov highlights the pronounced significant shift in research focus toward GLP-1 receptor agonists for a range of indications with at least some involvement of metabolic disorders. The site, which provides a robust but not-exhaustive snapshot of clinical trial activity, cites…Drug Discovery and Development See More >
New pharma and biotech manufacturing facilities and expansions announced worldwide for 2024
[Updated March 25, 2024] In the face of rising R&D costs and growing pricing pressures from payers, the pharma and biotech sectors continue to transform to adapt to an evolving landscape. While workforce reductions persist in 2024 for some companies, major players like AbbVie, AGC Biologics, and Amgen are demonstrating confidence in the industry with…
Sponsored Content See More >
Genomics/Proteomics See More >
NVIDIA expands BioNeMo platform with new foundation models and microservices for AI-powered Drug Discovery
NVIDIA is putting the power of generative AI for drug discovery into the hands of more pharmaceutical and biotech companies with an expanded collection of AI models and flexible deployment options. More than 100 firms are already using the company’s biomolecular BioNeMo platform to accelerate the development of therapeutics. “For the first time in history,…
Navigating the cancer progression pathway with liquid biopsy
Microsoft and 1910 Genetics: AI-powered partnership targets billion-dollar savings and growth in drug discovery
Culmination Bio partners with Merck on disease-agnostic patient data
Could an ‘extreme’ hibernating ground squirrel unlock new obesity treatments?
Infectious Disease See More >
Best-selling pharmaceuticals of 2023 reveal a shift in pharma landscape
Note: This feature on the best-selling pharmaceuticals of 2023 was updated on March 27. Changes are possible as more data become available. Sales of drugs with more than one developer are added together (as in the case of the COVID-19 vaccine Comirnaty) unless one of those companies records the net sales for it, i.e., Dupixent.…
Lumen Bioscience cracks the code on spirulina as a biologics factory for c. diff, metabolic disease and more
Vaccine mega-trials: Rare behemoths in the vaccine trial landscape
Biden names 31 tech hubs: Here are 10 relevant to pharma and biotech
An overview of the RSV vaccine landscape: GSK aims to extend its approval of Arexvy?
Oncology See More >
Pitt’s high-performance computing upgrade signals accelerated translational research
The University of Pittsburgh’s recent, significant expansion of its high-performance computing capabilities, courtesy of a gift from Dell Technologies, indicates a strategic commitment to using large-scale data analysis for faster translational research. The additional 9.672 gigaFLOPS of computational power – translating to nearly 9.7 trillion additional computations per second – could help Pitt’s Innovation Hub…